Table 3.
Subject | Stage | Sensitivity | ||
---|---|---|---|---|
FDG-PET | Pelvic MRI | PSA | ||
Clinical and Pathological stage | II or less | 31.5 (17/54) | 62.5 (15/24) | 90.4 (47/52) |
III | 22.2 (2/9) | 100.0 (5/5) | 100.0 (8/8) | |
IV | 80.0 (4/5) | 100.0 (2/2) | 66.7 (2/3) |
UICC: Union for International Cancer Control